Doç. Dr. MUHAMMED YUNUS BEKTAY

Yayın Ağı

Makaleler 69

1. Evaluation of albumin utilization, guideline compliance, and cost in intensive care units: a multicenter point prevalence study.

Çakır A., Ayhan Y. E., Bektay M. Y., Memiş H., Küçük R. S., Kınal A. G. K., et al.

BMC health services research , 2026 (SCI-Expanded, Scopus)

2. Impact of clinical pharmacist interventions on drug-related problems in hospitalised patients with renal dysfunction: a quasi-experimental study.

Özmen Ö., Bektay M. Y., Karatoprak C., İzzettin F. V.

Scientific reports , 2026 (SCI-Expanded, Scopus)

3. Reducing Enteral Feeding Tube Medication Errors in ICUs: A Multicenter Before-after Study of Education and Clinical Pharmacist Interventions in Türkiye.

Ayhan Y. E., Koçoğlu Kinal A. G., Eskidemir G., Özgan B., Yalçinkaya E., Kasapoğlu U. S., et al.

Journal of patient safety , 2026 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

4. Assessment of potential drug interactions in rheumatology: a comparative study of decision support software.

Şahin Y., Yildirim H. B., Okumuş H., Çakmak M., Ayhan Y. E., Özgan B., et al.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences , cilt.34, sa.1, 2026 (SCI-Expanded, Scopus)

5. Assessing medication discrepancies in pediatric patients: a cross-sectional feasibility study using the Medication Discrepancy Taxonomy (MedTax) in a pediatric ward.

Mercümek B., Bektay M. Y., Uzuner S., İzzettin F. V.

BMC pediatrics , cilt.25, sa.1, ss.904, 2025 (SCI-Expanded, Scopus)

6. Evaluation of clinical pharmacy services in patients receiving antithrombotic treatment in a randomized controlled trial

Sosyal D., Bektay M. Y., Acikgoz N., Izzettin F. V.

SCIENTIFIC REPORTS , cilt.15, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Cardiovascular comorbidities are risk factors for increased oxidative stress and DNA damage in migraine patients: a prospective cohort study

Gokce M., Bektay M. Y., Uzun M., Ulutas C., Uslu F., Guler E. M.

JOURNAL OF TRANSLATIONAL MEDICINE , cilt.23, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Identification and evaluation of drug-related problems in community pharmacy in Turkey: a descriptive prevalence study

Bektay M. Y., Ayhan Y. E., Çakmak M., Mercumek B.

BMC PRIMARY CARE , cilt.26, ss.1-12, 2025 (SCI-Expanded, Scopus)

9. Eczacıların İnsan Papilloma Virüsü (HPV) Aşılamasındaki Rolleri: Geleneksel Derleme

Özşahin R. B., Bektay M. Y.

Literatür Eczacılık Bilimleri Dergisi , cilt.14, sa.2, ss.93-104, 2025 (TRDizin) Sürdürülebilir Kalkınma

10. Exploring the Efficacy of Eletriptan and Dexketoprofen Through HIT-6, MIDAS, Allodynia, and VAS Assessments in Migraine

Gökçe M., Bektay M. Y., Uslu F., Güler E. M.

Haydarpaşa Numune Medical Journal , cilt.65, sa.2, ss.154-159, 2025 (TRDizin) Sürdürülebilir Kalkınma

11. Evaluation of the clinical pharmacist's effect on achieving treatment goals in patients with hypothyroidism: a randomized controlled trial.

Ayhan Y. E., Bektay M. Y., Gogas Yavuz D., Sancar M.

BMC endocrine disorders , cilt.25, sa.1, ss.94, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. KNOWLEDGE AND AWARENESS OF CELIAC DISEASE AND GLUTEN SENSITIVITY AMONG THE PUBLIC: A CROSS-SECTIONAL STUDY

Al-Taie A., BEKTAY M. Y.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.577, 2025 (SCI-Expanded, Scopus)

13. A CROSS-SECTIONAL ANALYSIS OF CLINICAL PHARMACIST IMPACT ON PREDIABETES MANAGEMENT

Kutluay N. B., YILMAZ H., Yusuf E., BEKTAY M. Y., MERCÜMEK B., SÜMBÜL ŞEKERCİ B., et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.536-537, 2025 (SCI-Expanded, Scopus)

14. PHARMACY STUDENT AND PHARMACISTS' KNOWLEDGE LEVELS AND ATTITUDES ABOUT ANTIMICROBIAL STEWARDSHIP PROGRAMS

Yusuf E., YILMAZ H., BEKTAY M. Y., MERCÜMEK B., İZZETTİN F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.535, 2025 (SCI-Expanded, Scopus)

15. KNOWLEDGE AND AWARENESS OF COMMUNITY PHARMACISTS REGARDING CELIAC DISEASE: A CROSS-SECTIONAL STUDY

Al-Taie A., BEKTAY M. Y.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.519, 2025 (SCI-Expanded, Scopus)

16. ANTIBIOTIC USE IN SURGICAL PROPHYLAXIS PRACTICES AND CLINICAL PHARMACIST CONTRIBUTIONS: AN OBSERVATIONAL STUDY

Cam E. O., PETEK V., ETÇİ E., BEKTAY M. Y., BALKAN İ. İ., İZZETTİN F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.529, 2025 (SCI-Expanded, Scopus)

17. PARENTS' KNOWLEDGE AND VACCINATION BEHAVIOUR REGARDING UPPER RESPIRATORY TRACT INFECTIONS: OBSERVATIONAL STUDY

ETÇİ E., PETEK V., Kaytan E., BEKTAY M. Y., MERCÜMEK B., Izettin F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.535-536, 2025 (SCI-Expanded, Scopus)

18. ASSESSING PEDIATRIC MEDICATION DISCREPANCIES IN A TURKISH HOSPITAL: A CROSS-SECTIONAL STUDY

MERCÜMEK B., BEKTAY M. Y., UZUNER S., İZZETTİN F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.503-504, 2025 (SCI-Expanded, Scopus)

19. EVALUATION OF UNIVERSITY STUDENTS' THALASSEMIA DISEASE KNOWLEDGE AND AWARENESS: A CROSS-SECTIONAL STUDY

Al-Taie A., BEKTAY M. Y.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.577-578, 2025 (SCI-Expanded, Scopus)

20. CLINICAL PHARMACIST ROLE IN ACHIEVING TREATMENT GOALS IN HYPOTHYROIDISM: A RANDOMIZED CONTROLLED TRIAL

Ayhan Y. E., BEKTAY M. Y., SANCAR M.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.569, 2025 (SCI-Expanded, Scopus)

21. Predictive Value of Natriuretic Peptide Tests and Ischemia Modified Albumin Levels in the Diagnosis of Obstructive Sleep Apnoea Syndrome

Ogun H., Güler E., Özkan B., Bektay M. Y., Kansu A., Çalım Ö.

The Turkish Journal of Ear Nose and Throat , cilt.35, sa.1, ss.35-40, 2025 (Scopus, TRDizin)

22. 52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice

Bektay M. Y.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.47, sa.2, ss.1-100, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Evaluation of the Effect of Management of Drug-Related Problems on Clinical Outcomes of Pulmonary Embolism Outpatients: A Randomized Controlled Trial

Ayhan Y. E., Aksoy M., Abdulrahman Y., Şahin Eröksüz Z. S., Vezir D., Mercümek B., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.14, ss.1-18, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Impact of clinical pharmacist integration on diabetes management: a prospective cohort.

Kutluay N. B., Bektay M. Y., Sumbul-Sekerci B., Sekerci A., Izzettin F. V.

BMC health services research , cilt.25, sa.1, ss.107, 2025 (SCI-Expanded, Scopus)

25. PHARMACIST INTERVENTIONS TO IMPROVE CLINICAL OUTCOMES IN HEART FAILURE

Bulut Y., Bektay M. Y.

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.49, sa.1, ss.1-9, 2025 (Scopus, TRDizin) Sürdürülebilir Kalkınma

26. Prevalence and Influencing Factors of Self-Medication with Analgesics Among Adults: An Observational Study

Bektay M. Y., Mercümek B., Koroglu F. N., İzzettin F. V.

FARMACIA , cilt.72, sa.6, ss.1450-1459, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Preface

BEKTAY M. Y., Ayhan Y. E., Altiparmak O.

The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings , 2024 (Scopus)

28. Pharmacist Services in the Aftermath of the February 6, 2023, Earthquake in Turkey: Lessons Learned

Yılmaz H., Yusuf E., Bektay M. Y.

DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS , cilt.18, ss.1-2, 2024 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

29. Pharmacists’s knowledge, attitude, and practices towards pharmaceutical and patient-centred care in asthma management: A national study

Çakmak D., Yunus Bektay M. Y., Al-Taie A., Ahmed Ali Jadoo S., Vehbi Izzettin F.

SAUDI PHARMACEUTICAL JOURNAL , cilt.32, ss.1-9, 2024 (SCI-Expanded, Scopus)

30. Assessment of drug-induced electrolyte disorders in intensive care units: a multicenter observational study

Ayhan Y. E., İlerler E. E., Sosyal D., Bektay M. Y., Karakurt S., Daşkaya H., et al.

FRONTIERS IN MEDICINE , cilt.11, ss.1-8, 2024 (SCI-Expanded, Scopus)

31. INAPPROPRIATE DRUG USE IN CRITICAL GERIATRIC CARE: A RETROSPECTIVE ANALYSIS ACCORDING TO STOPP-START CRITERIA

Karakurt Z., BEKTAY M. Y.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.46, sa.3, ss.765-766, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. An Assessment of Different Decision Support Software from the Perspective of Potential Drug–Drug Interactions in Patients with Chronic Kidney Diseases

Bektay M. Y., Buker Cakir A., Gursu M., Kazancioglu R., Izzettin F. V.

PHARMACEUTICALS , cilt.17, sa.5, ss.1-19, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Non-medical Use of Prescription Psychostimulants and Academic Performance in Medical Students

Sümbül Şekerci B., Bektay M. Y., Bildik Ö.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.14, ss.54-59, 2024 (ESCI, TRDizin)

34. Impact of structured patient education provided by clinical pharmacist on disease prognosis, adherence and quality of life in Type 2 Diabetes patients: An interventional study

Demirhan Ş., Bektay M. Y., Şekerci A., İzzettin F. V.

Acta Pharmaceutica Sciencia , cilt.62, sa.3, ss.660-677, 2024 (Scopus)

35. Anemi Tedavisinde Eczacının Rolü: İyi Uygulamalara ve Kanıta Dayalı Bir Sistematik Derleme

Yılmaz M. F. N., Bektay M. Y.

Literatür Eczacılık Bilimleri Dergisi , cilt.12, sa.3, ss.268-276, 2023 (TRDizin) Sürdürülebilir Kalkınma

36. Exploring Women’s Perspectives on Oral Contraceptives: The Role of Pharmacists in Shaping Attitudes

Bektay M. Y., Demirci P. N., Atak M.

Hitit medical journal (Online) , cilt.5, sa.3, ss.195-201, 2023 (TRDizin) Sürdürülebilir Kalkınma

37. A cross-sectional study on the knowledge of pharmacists about Alzheimer"s Disease: enhancing services for patients and caregivers

Zeybek E., Bektay M. Y.

ACTA PHARMACEUTICA SCIENCIA , cilt.61, sa.4, ss.355-369, 2023 (Scopus) Sürdürülebilir Kalkınma

38. Exploring the determinant of flu vaccine hesitancy among Turkish population: a cross-sectional study

Bektay M. Y., Ulaş M. H.

Journal of Ideas in Health , cilt.6, sa.3, ss.931-938, 2023 (Hakemli Dergi) Sürdürülebilir Kalkınma

39. Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers.

Gokce M., Velioglu H. A., Bektay M. Y., Guler E. M.

Gerontology , cilt.69, ss.1104-1112, 2023 (SCI-Expanded, Scopus)

40. Evaluation of Pharmacist Contribution to Adherence and Illness Perception in Hypertension: An Observational Study

Guruhan E., Bektay M. Y., Yılmaz Z., İzzettin F. V.

ANATOLIAN CLINIC JOURNAL OF MEDICAL SCIENCES , cilt.28, sa.3, ss.372-381, 2023 (TRDizin) Sürdürülebilir Kalkınma

41. PHARMACIST-LED ASSESSMENT OF ANXIETY LEVELS AND ASSOCIATED FACTORS: A PROSPECTIVE OBSERVATIONAL SURVEY

Bektay M. Y., Tütüncü B., Sosyal D., Atak M., İzzettin F. V.

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.47, sa.3, ss.944-956, 2023 (Scopus, TRDizin) Sürdürülebilir Kalkınma

42. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.29, sa.5, ss.1178-1186, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey

Hashemi F., Hoepner L., Hamidinejad F. S., Haluza D., Afrashteh S., Abbasi A., et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH , cilt.30, sa.28, ss.72368-72388, 2023 (SCI-Expanded, Scopus)

44. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

Bektay M. Y., Sancar M., Okyaltirik F., Durdu B., Izzettin F. V.

Frontiers in Pharmacology , cilt.13, 2023 (SCI-Expanded, Scopus)

45. Identification of Drug-Related Problems and Investigation of Related Factors in Patients with COVID-19: An Observational Study

Bektay M. Y., Sancar M., Okyaltırık F., Durdu B., İzzettin F. V.

BEZMIALEM SCIENCE , cilt.10, sa.6, ss.777-785, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma

46. Dynamic Thiol/Disulphide Homeostasis a Promising New Marker in the Diagnosis of Acute Appendicitis in Children: A Case Control Study of Acute Appendicitis and Abdominal Pain

Mirapoglu S. L., Guler E. M., BEKTAY M. Y., KOÇYİĞİT A., Vehbilzzettin F.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.12, sa.1, ss.82-86, 2022 (ESCI, TRDizin)

47. Factors associated with Turkish pharmacists' intention to receive COVID-19 vaccine: an observational study.

Okuyan B., Bektay M. Y., Demirci M. Y., Ay P., Sancar M.

International journal of clinical pharmacy , cilt.44, ss.247-255, 2022 (SCI-Expanded, SSCI, Scopus)

48. Reliability of High-Alert Medications Questionnaire in Turkish Healthcare Professionals

Ozturk F., Altiparmak O., Torun B., Bektay M. Y., SANCAR M., OKUYAN B.

BEZMIALEM SCIENCE , cilt.10, sa.1, ss.17-23, 2022 (ESCI, TRDizin)

49. Investigation of the Genotoxic, Cytotoxic, Apoptotic, and Oxidant Effects of Olive Leaf Extracts on Liver Cancer Cell Lines.

Bektay M. Y., Güler E. M., Gökçe M., Kızıltaş M. V.

Turkish journal of pharmaceutical sciences , cilt.18, sa.6, ss.781-789, 2021 (ESCI, Scopus, TRDizin)

50. Investigation of pharmaceutical care need of COVID-19 patients in hospital settings

Bektay M. Y., Sancar M., Okyaltırık F., Durdu B., İzzettin F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1777-1778, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

51. Investigation of potential drug-drug interaction in chronic kidney disease patients in nephrology clinic

Buker A., SOSYAL D., ÖZMEN Ö., BEKTAY M. Y., GÜRSU M., KAZANCIOĞLU R., et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1778, 2021 (SCI-Expanded, Scopus)

52. Community Pharmacy Cognitive Services During the COVID-19 Pandemic: A Descriptive Study of Practices, Precautions Taken, Perceived Enablers and Barriers, and Burnout.

Okuyan B., Bektay Y. M., Kingir Z. B., Save D., Sancar M.

International journal of clinical practice , cilt.75, sa.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Transcranial Magnetic Stimulation (TMS) Applications in Alzheimer's Disease: A Systematic Review

VelIoglu H. A., BEKTAY M. Y.

BEZMIALEM SCIENCE , cilt.9, sa.4, ss.503-511, 2021 (ESCI, TRDizin)

54. Attitudes of medicine, pharmacy, and dentistry students about psychostimulant use to enhance cognition.

Sümbül-Şekerci B., Bildik Ö., Bektay M. Y., İzzettin F. V.

International journal of clinical practice , cilt.75, sa.10, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Insight into Turkish Community Pharmacists' Services in the First Wave of the COVID-19 Pandemic.

Bektay M. Y., Okuyan B., Sancar M., Izzettin F. V.

Disaster medicine and public health preparedness , sa.3, ss.1-4, 2021 (SCI-Expanded, SSCI, Scopus)

56. Left Lateral Parietal rTMS Improves Cognition and Modulates Resting Brain Connectivity in Patients with Alzheimer's Disease: Possible Role of BDNF and Oxidative Stress.

Aziz Velioglu H., Hanoglu L., Bayraktaroglu Z., Toprak G., Metin Guler E., Yunus Bektay M. Y., et al.

Neurobiology of learning and memory , cilt.180, 2021 (SCI-Expanded, SSCI, Scopus)

57. Investigation of the Effects of Polypharmacy on Cognitive Functions: Cohort Study

BEKTAY M. Y., GÖKÇE M., Selvitop R., BOLAT E., Yildiz G. B.

INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH , cilt.55, sa.1, 2021 (SCI-Expanded, Scopus)

58. Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users.

Guler E. M., Bektay M. Y., Akyildiz A., Sisman B., Izzettin F. V., Kocyigit A.

Human & experimental toxicology , cilt.39, ss.1454-1462, 2020 (SCI-Expanded, Scopus)

59. Treatment of coronavirus disease 2019: a comprehensive review

Sosyal D., Ozmen O., Bektay M. Y., Izzettin F. V.

Journal of Ideas in Health , cilt.3, sa.4, ss.228-242, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

60. Time to change to improve health: clinical pharmacy and pharmaceutical care education in Turkey

Bektay M. Y., Sancar M., Ali Jadoo S. A., Izzettin F. V.

Journal of Ideas in Health , cilt.3, sa.1, ss.130-134, 2020 (Hakemli Dergi)

61. Inherited Epilepsies

Velioglu H. A., BEKTAY M. Y.

BEZMIALEM SCIENCE , cilt.8, sa.2, ss.182-188, 2020 (ESCI, TRDizin)

62. Comparision of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic

BEKTAY M. Y., Seker Z., Eke H. K., TÜRK H. M., İZZETTİN F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.42, sa.1, ss.229, 2020 (SCI-Expanded, Scopus)

63. Investigation of the associatoin between polypharmacy and alzheimer disease

BEKTAY M. Y., GÖKÇE M., Selvitop R., BOLAT E., Yildiz G. B.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.42, sa.1, ss.283, 2020 (SCI-Expanded, Scopus)

64. Investigation of the Effects of Biochemical Parameters on Alzheimer's Disease

Gokce M., Bektay M. Y., Selvitop R., Toprak A., Yildiz G.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS , cilt.34, ss.464-468, 2019 (SCI-Expanded, Scopus)

65. The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment

İZZETTİN F. V., Çelik S., Acar R. D., TEZCAN S., Aksoy N., BEKTAY M. Y., et al.

Journal of Research in Pharmacy , cilt.23, sa.6, ss.1157-1163, 2019 (Scopus)

66. Blok Zincir Teknolojisi ve Medikal Uygulamaları

BEKTAY M. Y.

HAYAT SAĞLIK DERGİSİ , sa.12, ss.40-43, 2018 (Hakemsiz Dergi)

67. Prof. Dr. Abdurrahim Koçyiğit ile “Geleneksel ve Tamamlayıcı Tıp Uygulamaları” üzerine (Söyleşi)

Bildik Ö., Bektay M. Y.

Hayat Sağlık ve Sosyal Bilimler Dergisi , sa.17, ss.62-69, 2018 (Hakemsiz Dergi)

68. Quantifying structural and electromagnetic interference (EMI) shielding properties of thermoplastic polyurethane-carbon nanofiber/magnetite nanocomposites

Durmus Z., Durmus A., Bektay M. Y., Kavas H., Unver I. S., Aktas B.

JOURNAL OF MATERIALS SCIENCE , cilt.51, sa.17, ss.8005-8017, 2016 (SCI-Expanded, Scopus)

69. Therapeutic effects of Licorice (Glycyrrhiza glabra) on colitis through its antioxidant properties and biochemical analyses

Uckaya F., Bektay Y., Yilmaz A., Bayindir N., Selek Ş., Topcu G., et al.

ANTI-CANCER DRUGS , cilt.26, 2015 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 39

1. Behaviour change support education in chronic disease: A cross-sectional survey of undergraduate European students

Mercümek B., Bektay M. Y., Pasin Ö., Félix I. B., Marques M., Guerreiro M. P.

82nd FIP World Congress of Pharmacy and Pharmaceutical Sciences in Cape Town, South Africa, 1 to 4 September 2024, Cape-Town, Güney Afrika, 1 - 04 Eylül 2024, ss.4-5, (Özet Bildiri)

2. A Study of The Association Between Medication Adherence and Self-Care Activities In Patients With Type 2 Diabetes Mellitus.

Demirhan Ş., Bektay M. Y., Şekerci A., Güler E. M., İzzettin F. V.

4. International Hasankeyf Scientific Research And Innovation Congress , Batman, Türkiye, 30 Nisan 2023, ss.388, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Investigation of drug-related problems in hospitalized patients with respiratory diseases: a randomized controlled trial

Bektay M. Y., Sancar M., Okyaltirik F., Durdu B., Izzettin F. V.

50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care, Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1484, (Özet Bildiri)

4. Identification of potentially inappropriate medications in elderly according to the FORTA and EU (7)-PIM lists: an observational study

Ozmen O., Bektay M. Y., Karatoprak C., Izzettin F. V.

50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care. , Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1528-1529, (Özet Bildiri)

5. Evaluation of analgesic use behaviors of individuals for pain management: an observational study

Koroglu F. N., Mercumek B., Bektay M. Y., Izzettin F. V.

50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care., Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1503, (Özet Bildiri)

6. Identification and evaluation of drug-related problems in the cardiology ward: an interventional study

Sosyal D., Bektay M. Y., Acikgoz N., Izzettin F. V.

50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care., Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1520, (Özet Bildiri)

7. ECZACILARIN ASTIM FARMASÖTİK BAKIMINDA BİLGİ SEVİYESİ TUTUM VE DAVRANIŞLARININ ARAŞTIRILMASI

Çakmak D., Bektay M. Y., Al-Ezzi S. A. A., İzzettin F. V.

İstanbul 3rd International Modern Scientific Research Congress, İstanbul, Türkiye, 6 - 08 Mayıs 2022, ss.169-171, (Özet Bildiri)

8. FARMASÖTİK BAKIM HİZMETİNİN DİYABET PROGNOZUNA ETKİLERİNİN DEĞERLENDİRİLMESİ

Kutluay N. B., Bektay M. Y., Sümbül Şekerci B., Şekerci A., İzzettin F. V.

Istanbul 3rd Internatıonal Modern Scıentıfıc Research Congress , İstanbul, Türkiye, 6 - 08 Mayıs 2022, ss.56-57, (Özet Bildiri) Sürdürülebilir Kalkınma

9. ASSOCIATION OF PLASMA DIAZEPAM BINDING INHIBITOR WITH INFLAMMATORY, OXIDATIVE STRESS AND NEURODEGENERATIVE MARKERS IN ALZHEIMER'S DISEASE

Gökçe M., Bektay M. Y., Velioğlu H. A., Güler E. M.

26TH NATIONAL and 1ST INTERNATIONAL PHARMACOLOGY CONGRESS, 4 - 06 Kasım 2021, ss.166-167, (Özet Bildiri)

10. Determination of the Knowledge Level Of Pharmacists About Alzheimer Disease

Zeybek E., Bektay M. Y., İzzettin F. V.

3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.90, (Özet Bildiri)

11. Determination of Pharmaceutical Care Needs of COVID-19 Patients in the 1st Wave of Pandemic

Gökçe N., Bektay M. Y., İzzettin F. V.

3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.87, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Investigation of the Anxiety and Knowledge Levels of Individuals: the Role of Pharmacist

Tütüncü B., Sosyal D., Bektay M. Y., İzzettin F. V.

3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.89, (Özet Bildiri)

13. Are Students Using Pharmacological Cognitive Enhancement More Successful?

Sümbül Şekerci B., Bektay M. Y., Bildik Ö., İzzettin F. V.

49th Meeting of the European Brain and Behaviour Society, Lausanne, İsviçre, 4 - 07 Eylül 2021, ss.259, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Serum Lityum Düzeyi Yüksek Olan Hastada Olası İlaçla İlgili Problemler: Bir Olgu Raporu

Özmen Ö., Sosyal D., Bektay M. Y., Gürsoy A. E., İzzettin F. V.

OLGULARLA KLİNİK ECZACILIK ÇALIŞTAYI, İstanbul, Türkiye, 17 Haziran 2021, ss.3, (Özet Bildiri)

15. Levodopa Kullanımına Bağlı Olası İlaç Kaynaklı Pansitopeni: Bir Olgu Raporu

Özkanlı Ö. F., Bektay M. Y., Karatoprak C., İzzettin F. V.

OLGULARLA KLİNİK ECZACILIK ÇALIŞTAYI, İstanbul, Türkiye, 17 Haziran 2021, ss.7, (Özet Bildiri)

16. Böbrek Yetmezliğinde Alfa-1 Adrenerjik Reseptör Blokör Kullanımı: Bir Olgu Raporu

Bekler T., Bektay M. Y., Karatoprak C., İzzettin F. V.

OLGULARLA KLİNİK ECZACILIK ÇALIŞTAYI, İstanbul, Türkiye, 17 Haziran 2021, ss.13, (Özet Bildiri)

17. Comparision of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic

BEKTAY M. Y., Şeker Z., eke h. k., TÜRK H. M., İZZETTİN F. V.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, Lübiyana, Slovenya, 23 - 25 Ekim 2020, cilt.42, ss.229, (Özet Bildiri)

18. Neurotrophic and antioxidant effect of rTMS in Alzheimer's Disease.

Velioğlu H. A., Güler E. M., Mutlu-Burnaz ., Bektay M. Y., Hanoglu L.

FENS 2020 Virtual Forum, Glasgow, Birleşik Krallık, 16 - 18 Temmuz 2020, ss.1754, (Özet Bildiri)

19. Neurotrophic and antioxidant effect of rTMS in Alzheimer’xxs Disease

VELİOĞLU H. A., GÜLER E. M., Oznur M. B., BEKTAY M. Y., HANOĞLU L.

FENS 2020 Virtual Forum, 11 - 15 Temmuz 2020, (Özet Bildiri)

20. INVESTIGATION OF THE ASSOCIATION BETWEEN POLYPHARMACY AND ALZHEIMER DISEASE

Bektay M. Y., Gökçe M., Selvitop R., Bolat E., Yıldız G.

ESCP 2019 Symposium, Ljubljana, Slovenya, 23 - 25 Ekim 2019, ss.283, (Özet Bildiri)

21. Comparison of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic.

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.

48TH SYMPOSIUM OF EUROPEAN SOCIETY OF CLINICAL PHARMACY (ESCP), Ljubljana, Slovenya, 22 Ekim 2019, cilt.42, ss.229, (Özet Bildiri)

22. Comparison of Different Decision Support Software Programs in Perspective of Potential Drug-Drug Interactions In Oncology Clinic

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.

48th ESCP Symposium. The Digital Revolution: Supporting clinical pharmacy through e-health, digital support systems, big data and more., Ljubljana, Slovenya, 23 - 25 Ekim 2019, ss.229, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Investigation of the associatoin between polypharmacy and alzheimer disease

BEKTAY M. Y., Gokce M., Selvitop R., Bolat E., Yildiz G. B.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 23 - 25 Ekim 2019, cilt.42, ss.283, (Özet Bildiri)

24. Hepatoselüler Karsinoma, Mide ve Kolorektal Kanser Hastalarında Tedavi Öncesi ve Sonrası Oksidatif Stresin Araştırılması

Bozbulut E., GÖKÇE M., BEKTAY M. Y., Serilmez M., Uzun M., Aksoy T., et al.

1st INTERNATIONAL MULTIDISCIPLINARY CANCER RESEARCH CONGRESS, 18 - 22 Eylül 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

25. Yetim İlaçların Mevcut Durumu ve Eczacının Rolü

ŞEKER Z., BEKTAY M. Y., BABALI BALIBEY F., ŞAHİN H.

3. Ulusal Klinik Eczacılık Kongresi., Türkiye, 09 Şubat 2017, (Özet Bildiri)

26. ‘Yetim İlaçların Mevcut Durumu ve Eczacının Rolü

BEKTAY M. Y.

3. Ulusal Klinik Eczacılık Kongresi, Antalya, Türkiye, 09 Şubat 2017, ss.40, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

27. Investigation of effects of olive (Olea europaea l.) Leaves on liver cell lines

BEKTAY M. Y., GÜLER E. M., UÇKAYA F., TOPÇU G., KOÇYİĞİT A.

6. Multidisipliner Kanser Araştırma Kongresi, Konya, Türkiye, 27 Ekim 2016, ss.40, (Tam Metin Bildiri)

28. Antioxidant and toxicological in-vivo and in-vitro examination of licorice extract

Bektay M. Y., Uckaya F., Guler E. M., Bayindir N., Kocyigit A., Esrefoglu M., et al.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.144, (Özet Bildiri)

29. Anti-Oxidant, Cytotoxic And Genotoxic Investigations Of Olea europaea Leaves.

BEKTAY M. Y., GÜLER E. M., Kızıltaş M. V., UÇKAYA F., KOÇYİĞİT A., TOPÇU G.

2. IVEK Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 27 Kasım 2015, ss.65, (Tam Metin Bildiri)

30. Synthesis, characterization and application of graphene/noble metal nanocomposites in photocatalytic dye elimination processes

ZENGİN KURT B., BEKTAY M. Y., DURMUŞ Z., Sonmez G., Korkmaz S.

2nd Graphene and Related Technologies: from Laboratory to Industry, İstanbul, Türkiye, 15 Kasım 2015, ss.40, (Tam Metin Bildiri)

31. Investigation of Anti-Oxidant and Toxicological Effects Of Methanolic Extract of Rosmarinus officinalis

BEKTAY M. Y., UÇKAYA F., BAYINDIR N., TOPÇU G., EŞREFOĞLU M.

International Multidisciplinary Symposium on Drug Research & Development, Eskişehir, Türkiye, 15 Ekim 2015, ss.65, (Tam Metin Bildiri)

32. Antiprotease and Antioxidant Activities of Salvia montbretii.

Uçakaya M., UÇKAYA F., BEKTAY M. Y., TOPÇU G.

International Multidisciplinary Symposium on Drug Research & Development, Eskişehir, Türkiye, 15 Ekim 2015, ss.76, (Tam Metin Bildiri)

33. Investigation of Antioxidant and Toxicological Effects of Methanolic Extract of Rosmarinus offıcinalis

BEKTAY M. Y., UÇKAYA F., BAYINDIR N., TOPÇU G., EŞREFOĞLU M.

International Multidisciplinary Symposium on Drug Research & Development, Eskişehir, Türkiye, 15 - 17 Eylül 2015, (Özet Bildiri)

34. Investigation of In-Vitro and In-Vivo Anti-Oxidant Effects of Matricaria chamomilla Extract on Rat Model of Ulcerative Colitis.

Bektay M. Y., Uçkaya F., Topçu G., Eşrefoğlu M., Bayındır N.

1st International Conference on Natural Products for Cancer Prevention and Therapy, İstanbul, Türkiye, 31 Ağustos 2015, (Tam Metin Bildiri)

35. 1st International Conference on Natural Products for Cancer Prevention and Therapy 31 August-2 September 2015 Istanbul, Turkey (vol 26, pg e1, 2015)

BEKTAY M. Y., Uckaya F.

ANTI-CANCER DRUGS, 29 - 31 Ağustos 2015, cilt.27, ss.76 Sürdürülebilir Kalkınma

36. Therapeutic effects of Licorice (Glycyrrhiza glabra) on colitis through its antioxidant properties and biochemical analyses

Uckaya F., BEKTAY M. Y.

ANTI-CANCER DRUGS, 29 - 31 Ağustos 2015, cilt.26, ss.24-25

37. Structural and electromagnetic interference (EMI) shielding properties of flexible polymer nanocomposite films including novel type functional nano fillers

DURMUŞ Z., BEKTAY M. Y., KAŞGÖZ A., DURMUS A., KAVAS H., AKTAS B.

International Conference on Advances in Functional Materials (AFM 2015), New York, Amerika Birleşik Devletleri, 29 Haziran 2015, ss.176, (Özet Bildiri)